Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Nichols Q1 revenues fall as international sales drop

(Sharecast News) - Soft drinks group Nichols has held on to full-year forecasts despite a mixed performance in the first quarter which saw group revenues fall nearly 6%. The company, known for Vimto as well other portfolio brands like Slush Puppie and Sunkist, announced on Wednesday that strong growth in the UK Packaged division was offset by an anticipated decline in International revenue.

UK Packaged revenues were up 6.8% on last year at £20.4m, with underlying volumes growing by 4.4%.

However, International Packaged revenues dropped 23% to £9.8m, which Nichols said was due to the phasing of shipments and strong prior-year comparatives, along with the continued "rationalisation" and focus on profitability in the Out of Home (OoH) business.

Revenues from the OoH unit - which serves post-mix soft drinks to places like cinemas and other hospitality venues - were down 6.2% at £8.6m as expected, as the company continues to withdraw from unprofitable accounts. However, these actions are having a positive effect on profits, the company said.

All in all, group revenues were down 5.9% year-on-year to £38.8m.

Nevertheless, Nichols said the board remains confident that it can hit consensus forecasts for an adjusted pre-taxp profit of £28.8m for 2024, compared with £27.2m in 2023.

Shares were down 1.3% at 986.7p by 1045 BST.

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.